ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

June 13, 1980

Herberman Outlines NSABP restructuring In Plan To NCI

May 6, 1994

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009

Bethesda System Revised For Reporting Pap Test Results

April 26, 2002

Sole Source Negotiations

March 7, 1975

Another HHS Recommendation: Screen 50 And Older For Colorectal Cancer;

March 15, 2002